These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 24953254)
1. IGFBP-3: a cell fate pivot in cancer and disease. Johnson MA; Firth SM Growth Horm IGF Res; 2014 Oct; 24(5):164-73. PubMed ID: 24953254 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology and biology of insulin-like growth factor binding protein-3 (IGFBP-3) as an anti-cancer molecule. Ali O; Cohen P; Lee KW Horm Metab Res; 2003; 35(11-12):726-33. PubMed ID: 14710351 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400 [TBL] [Abstract][Full Text] [Related]
4. IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments. Grkovic S; O'Reilly VC; Han S; Hong M; Baxter RC; Firth SM Oncogene; 2013 May; 32(19):2412-20. PubMed ID: 22751133 [TBL] [Abstract][Full Text] [Related]
5. Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Williams AC; Collard TJ; Perks CM; Newcomb P; Moorghen M; Holly JM; Paraskeva C Cancer Res; 2000 Jan; 60(1):22-7. PubMed ID: 10646845 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells. Lochrie JD; Phillips K; Tonner E; Flint DJ; Allan GJ; Price NC; Beattie J J Cell Physiol; 2006 May; 207(2):471-9. PubMed ID: 16419030 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome. Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160 [TBL] [Abstract][Full Text] [Related]
8. Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. Firth SM; Fanayan S; Benn D; Baxter RC Biochem Biophys Res Commun; 1998 May; 246(2):325-9. PubMed ID: 9610357 [TBL] [Abstract][Full Text] [Related]
9. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Burger AM; Leyland-Jones B; Banerjee K; Spyropoulos DD; Seth AK Eur J Cancer; 2005 Jul; 41(11):1515-27. PubMed ID: 15979304 [TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-3 induces G1 cell cycle arrest with inhibition of cyclin-dependent kinase 2 and 4 in MCF-7 human breast cancer cells. Kim HS; Lee WJ; Lee SW; Chae HW; Kim DH; Oh Y Horm Metab Res; 2010 Mar; 42(3):165-72. PubMed ID: 19960406 [TBL] [Abstract][Full Text] [Related]
11. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. Lin MZ; Marzec KA; Martin JL; Baxter RC Oncogene; 2014 Jan; 33(1):85-96. PubMed ID: 23178489 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. Liu B; Lee KW; Anzo M; Zhang B; Zi X; Tao Y; Shiry L; Pollak M; Lin S; Cohen P Oncogene; 2007 Mar; 26(12):1811-9. PubMed ID: 16983336 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models. Kojima S; Mulholland DJ; Ettinger S; Fazli L; Nelson CC; Gleave ME Prostate; 2006 Jun; 66(9):971-86. PubMed ID: 16541420 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation. Santer FR; Moser B; Spoden GA; Jansen-Dürr P; Zwerschke W Carcinogenesis; 2007 Dec; 28(12):2511-20. PubMed ID: 17827406 [TBL] [Abstract][Full Text] [Related]
15. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts. Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210 [TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor. Li J; Jin D; Fu S; Mei G; Zhou J; Lei L; Yu B; Wang G Biochem Biophys Res Commun; 2013 Jul; 436(4):632-7. PubMed ID: 23770368 [TBL] [Abstract][Full Text] [Related]
17. Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro. Mochizuki T; Sakai K; Iwashita M Growth Horm IGF Res; 2006 Jun; 16(3):202-10. PubMed ID: 16844395 [TBL] [Abstract][Full Text] [Related]
18. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. Frommer KW; Reichenmiller K; Schutt BS; Hoeflich A; Ranke MB; Dodt G; Elmlinger MW J Mol Endocrinol; 2006 Aug; 37(1):13-23. PubMed ID: 16901920 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Levitt RJ; Buckley J; Blouin MJ; Schaub B; Triche TJ; Pollak M Biochem Biophys Res Commun; 2004 Apr; 316(2):421-8. PubMed ID: 15020235 [TBL] [Abstract][Full Text] [Related]
20. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors. Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]